C12N 2820/10
Multiple origins of replication
Official title: multiple origins of replication
C12N2820/10 (Multiple origins of replication) appears on 9 US grants and 27 published applications in this corpus.
Search patents in C12N- Granted patents
- 9
- Published applications
- 27
- Assignees
- 17
- Inventors
- 55
- Latest grant
- 17 Jun 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2006 | 0 | 2 |
| 2007 | 0 | 0 |
| 2008 | 0 | 3 |
| 2009 | 0 | 0 |
| 2010 | 1 | 1 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 1 | 1 |
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 1 | 2 |
| 2018 | 0 | 1 |
| 2019 | 1 | 3 |
| 2020 | 2 | 2 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 2 | 2 |
| 2024 | 0 | 5 |
| 2025 | 1 | 2 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Phagemid vector17 Jun 2025US 12,331,308 B2Imperial College Innovations Limited
- Cancer treatment21 Nov 2023US 11,820,792 B2Imperial College Innovations Limited
- Phagemid vector14 Mar 2023US 11,603,540 B2Imperial College Innovations Limited
- PDL1 block CAR-T transgenic vector for suppressing immune escape, preparation method thereof, and application of the same11 Aug 2020US 10,736,920 B2Shanghai Unicar-Therapy Bio-Medicine Technology Co., Ltd
- Expression and secretion system28 Apr 2020US 10,633,650 B2Genentech, Inc.
- Components for genomic editing13 Aug 2026US 2026/0234657 A1Kano Therapeutics Inc.
- Expression and secretion system30 Oct 2025US 2025/0333723 A1Genentech, Inc.
- Method for Producing Plasmid, and Plasmid11 Sep 2025US 2025/0283057 A1Spiber Inc.
- Recombinant aav constructs for increased transgene expression14 Nov 2024US 2024/0376494 A1Wisconsin Alumni Research Foundation
- Self-replicating dna expression system and immunogen17 Oct 2024US 2024/0344100 A1
Most cited
By later US patents
- PDL1 block CAR-T transgenic vector for suppressing immune escape, preparation method thereof, and application of the same3US 10,736,920 B2Shanghai Unicar-Therapy Bio-Medicine Technology Co., Ltd · 2020
- Phagemid vector2US 11,603,540 B2Imperial College Innovations Limited · 2023
- Methods and materials for expression of a recombinant protein2US 7,794,976 B2Xoma Technology Ltd. · 2010
- Cancer treatment1US 11,820,792 B2Imperial College Innovations Limited · 2023
- Viral expression plasmids for production of proteins, antibodies, enzymes, virus-like particles and for use in cell-based assays1US 8,377,653 B2Icosagen Cell Factory OÜ · 2013